GIÈRES (GRENOBLE), France and NASHVILLE, Tenn., July 22, 2024 /PRNewswire/ -- eCential Robotics is proud to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an innovative Spine Navigation and Robotic-Assistance Device. This device provides a new, advanced solution for planning and instrumenting spinal fusion procedures..

GIÈRES（格勒诺布尔），法国和田纳西州纳什维尔，2024年7月22日/PRNewswire/--eCential Robotics骄傲地宣布，它已经获得美国食品和药物管理局（FDA）510（k）的许可，用于创新脊柱导航和机器人辅助装置。该设备为计划和检测脊柱融合程序提供了一种新的先进解决方案。。

This spine robot was developed by eCential Robotics in the framework of a collaboration with DePuy Synthes (DPS), The Orthopaedics Company of Johnson & Johnson. DPS will leverage its extensive reach and expertise to bring this innovative solution to market.

这种脊柱机器人是由eCential Robotics在与强生骨科公司DePuy Synthes（DPS）合作的框架内开发的。DPS将利用其广泛的影响力和专业知识，将这一创新解决方案推向市场。

This milestone achievement highlights eCential Robotics' unique expertise in the field of surgical navigation and robotics, reaffirming its dedication to supporting and advancing the healthcare system.

这一里程碑式的成就突显了eCential Robotics在手术导航和机器人领域的独特专业知识，重申了其支持和推进医疗保健系统的决心。

'This additional FDA clearance is a testament to our relentless pursuit of innovation and excellence in the field of surgical robotics and navigation,' said Clément Vidal, CEO at eCential Robotics. 'We look forward to continuing to deliver cutting-edge solutions that enhance surgical precision and patient outcomes.'.

eCential robotics首席执行官克莱门特·维达尔（ClémentVidal）说：“FDA的这一额外批准证明了我们在手术机器人和导航领域不懈追求创新和卓越。”我们期待着继续提供先进的解决方案，以提高手术精度和患者预后。”。

About eCential Robotics

关于基本机器人

eCential Robotics is a French and US-based company, founded by Stéphane Lavallée and part of the Grenoble Haventure network, specializing in surgical robotics. It has developed an open, unified yet modular, and scalable 2D/3D imaging, navigation, and robotic platform aiming to improve bone surgery outcomes.

eCential Robotics是一家总部位于法国和美国的公司，由Stéphane Lavallée和格勒诺布尔Haventure网络的一部分创立，专门从事手术机器人。它开发了一个开放，统一但模块化且可扩展的2D/3D成像，导航和机器人平台，旨在改善骨手术结果。

With more than 100 patents and 7 trademarks, eCential Robotics is pursuing a disruptive innovation strategy enabling third parties to develop surgical Apps in its ecosystem. Thanks to multiple partnerships already established with implant manufacturers, tech companies, and research labs, eCential Robotics is positioned as a leader in the fast-growing surgical robotics market and aspires to become the world leader in open robotic platforms..

eCential Robotics拥有100多项专利和7项商标，正在推行颠覆性创新战略，使第三方能够在其生态系统中开发外科应用程序。由于已经与植入物制造商、技术公司和研究实验室建立了多种合作伙伴关系，eCential Robotics被定位为快速增长的外科机器人市场的领导者，并渴望成为开放机器人平台的世界领导者。。